Insight into the Chinese orthopedic surgical robot market in the first three quarters of 2024

So far in 2022, the number of domestic orthopedic surgical robot registrations has surged, with the domestic production ratio exceeding 90% as of now. At the end of the third quarter of 2024, the domestic orthopaedic surgical robot market reached a domestic production rate of about 65%. The market share of domestic orthopaedic surgical robots will further increase in the future with the layout of new products at the hospital end.

01  Overall market
| 1. Market size
In the first three quarters of 2024, the domestic orthopedic surgery robot market size did not change much from the same period last year, down 1.28% year-on-year.

Figure 1 2023Q1-Q3 VS 2024Q1-Q3 Domestic orthopedic surgery robot market size and changes

Data source:Yizhuagnshusheng (market situation by amount, the same below; YOY refers to year-on-year growth rate)

|2. Market pattern
(1) Localization rate
In the first three quarters of 2024, the domestic localisation rate of domestic orthopaedic surgical robots in the market remained stable at over 65%, a slight decrease from the same period last year. With the rapid growth of domestic registration certificates in the past three years, the domestic share has exceeded 90% by the end of the third quarter of 2024, and the domesticisation rate of orthopaedic surgical robots in the market is expected to increase further.
Figure 2 2023Q1-Q3 VS 2024Q1-Q3 Domestic Domestic Orthopaedic Surgical Robots Market Localisation Rate

Data source:：Yizhuagnshusheng

Figure 3 Localization rate of orthopedic surgical robots in the domestic market from 2021 to Q3 2024

Data source: Yizhuagnshusheng Based on the national and provincial and municipal drug administration disclosure data statistics

(1) Brand pattern
In the first three quarters of 2024, Tinavi, Stryke, Medtronic, and Jianjia consistently ranked among the top four in the domestic orthopedic surgical robot market in terms of market share. The market concentration of the top four brands (CR4) decreased from 88.25% in the first three quarters of 2023 to 73.52%, a decrease of about 15%.In terms of scope of application, in the domestic market in the first three quarters of 2024, orthopedic surgical robots suitable for joint surgery were the most widely used, followed by spinal surgery robots, and the procurement proportion has increased compared with the same period last year.

Figure 4 Market composition of various types of orthopedic surgical robots in China between 2023Q1-Q3 and 2024Q1-Q3

Data Source：Yizhuagnshusheng

① Joint orthopedic surgical robot
In the first three quarters of 2024, Tinavi, Stryke, and Jianjia maintained their top three market shares in the domestic orthopedic surgical robot market, while Yuanhua Robotics, Perception, and AI Technologies ranked fourth. Among them, CR4 reached 84.75%, a decrease of nearly 15% year-on-year.

② Spinal surgery robot
In the first three quarters of 2024, Tinavi and Medtronic ranked the top two in the domestic spine surgery robot market, and Tuodao Medical and Resilienc ranked among the top four. Among them, CR4 reached 93.56%, a decrease of nearly 6%.
③ Trauma orthopedic surgical robot
In the first three quarters of 2024, Tianzhihang still held a dominant position in the domestic spinal surgery robot market, with a market share of 97.30%, an increase of over 7% compared to the same period last year.

02 Regional market

|1. Joint orthopedic surgical robot
In the first three quarters of 2024, the proportion of domestic joint orthopedic surgical robots purchased in the eastern region increased significantly, while the proportion in the central region decreased significantly.

In the report, the eastern region includes 10 provinces (cities) including Beijing, Tianjin, Hebei, Shanghai, Jiangsu, Zhejiang, Fujian, Shandong, Guangdong, and Hainan; The central region includes six provinces: Shanxi, Anhui, Jiangxi, Henan, Hubei, and Hunan; The western region includes 12 provinces (districts and cities) in Inner Mongolia, Guangxi, Chongqing, Sichuan, Guizhou, Yunnan, Xizang, Shaanxi, Gansu, Qinghai, Ningxia and Xinjiang; The Northeast region includes Liaoning, Jilin, and Heilongjiang.
From the perspective of brand market share, Tinavi ranks first in both the western and central regions of China, and has relative advantages in both the eastern and northeastern regions, with the most prominent advantage in the western region; Stryke and MicroPort Medical are located in the eastern and northeastern regions respectively

|2、Spinal surgery robot

In the first three quarters of 2024, the purchase proportion of domestic spinal surgical robots only increased in the western region, and the other three regions showed a downward trend to varying degrees, of which the eastern region declined most significantly.

|3. Traumatic orthopedic surgery robot
In the first three quarters of 2024, the proportion of domestic orthopaedic trauma surgery robots in the western region increased significantly, and the central region decreased significantly.

03  Procurement at the hospital end

| 1、 Overall situation
In the first three quarters of 2024, domestic orthopaedic surgical robots were still mainly distributed in third-level hospitals, and the proportion of orthopaedic surgical robots purchased by second-level, first-level and other ungraded hospitals has increased. It has become an inevitable trend of market development to penetrate into regional medical institutions from advantageous hospitals in first – and second-tier cities.
In the first three quarters of 2024, domestic orthopaedic surgical robots were still mainly distributed in third-level hospitals, and the proportion of orthopaedic surgical robots purchased by second-level, first-level and other ungraded hospitals has increased.

① Orthopedic joint surgery robot
From the perspective of the market pattern of orthopedic joint surgery robots in domestic tertiary and secondary hospitals, Tinavi, Stryke and Jianjia Medical had obvious advantages in tertiary hospitals in the first three quarters of 2024, while the secondary hospital market was almost monopolized by Tinavi.

② Spinal surgery robot
From the perspective of the market pattern of spinal surgery robots in domestic tertiary and secondary hospitals, in the first three quarters of 2024, tertiary hospitals Tinavi,Medtronic and Tuodao Medical had obvious advantages, and the main brands in secondary hospitals were Tinavi and PERLOVE MEDICAL.
2. County hospitals
In the first three quarters of 2024, the purchase proportion of orthopedic surgical robots in domestic county-level hospitals reached 16.89%, an increase of 6.47% over the same period last year. Orthopedic surgical robots purchased by county hospitals were mainly domestic brands such as Tinavi, Yuanhua Robotics,.Perception and Al Technologies, Lancet Robotics and Santa Medical.

China is encouraging China end uses for more domestic products in latest years. Thus, more and more overseas manufacturers are planning localization in China. BradyKnows localization team has extensive experiences in facility establishment, audit, supplier evaluation, manufacturing, registration, and marketing in China. Pls feel free to let us know any questions on China entry via info@bradyknowsmedical.com

Source：Yizhuangshusheng
Translated & edited： Bradyknow